Newbury Pharmaceuticals AB (publ) (STO:NEWBRY)
Sweden · Delayed Price · Currency is SEK 1.665
+0.145 (9.54%)
Nov 4, 2026, 5:25 PM CET
STO:NEWBRY Market Cap
STO:NEWBRY has a market cap or net worth of 50.61 million as of November 4, 2026. It is the 45,071st most valuable company in the world and the 683rd biggest in Sweden. Its market cap has decreased by 20.71% in one year.
Market Cap
50.61M
Enterprise Value
41.27M
Revenue
44.39M
Global Rank
Country Rank
#683 Sweden
PE Ratio
n/a
ChartMarket Cap Chart
Since February 4, 2022, STO:NEWBRY's market cap has decreased from 245.97M to 50.61M, a decrease of -79.42%. That is a compound annual growth rate of -28.31%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 4, 2026 | 50.61M | 44.78% |
| Dec 30, 2025 | 34.96M | -59.06% |
| Dec 30, 2024 | 85.39M | 42.48% |
| Dec 29, 2023 | 59.93M | -56.08% |
| Dec 30, 2022 | 136.45M | -44.52% |
| Feb 4, 2022 | 245.97M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Dicot Pharma AB | 749.24M |
| Cereno Scientific AB | 732.55M |
| EQL Pharma AB | 602.40M |
| Enzymatica AB | 582.56M |
| Cinclus Pharma Holding AB | 544.49M |
| Moberg Pharma AB | 505.78M |
| Orexo AB | 169.42M |
| Klaria Pharma Holding AB (publ.) | 122.99M |